Invention Grant
- Patent Title: Treatment of immunosuppressed subjects
-
Application No.: US17284406Application Date: 2019-10-11
-
Publication No.: US11701408B2Publication Date: 2023-07-18
- Inventor: Patrick Soon-Shiong
- Applicant: Nantcell, Inc.
- Applicant Address: US CA Culver City
- Assignee: NantCell, Inc.
- Current Assignee: NantCell, Inc.
- Current Assignee Address: US CA Culver City
- Agency: Sheridan Ross P.C.
- International Application: PCT/US2019/055790 2019.10.11
- International Announcement: WO2020/077180A 2020.04.16
- Date entered country: 2021-04-09
- Main IPC: A61K38/20
- IPC: A61K38/20 ; A61K38/17 ; A61K47/64 ; A61K31/536 ; A61K31/7068 ; A61K31/7072 ; A61K31/52 ; A61K31/675 ; A61K31/496 ; A61K31/635 ; A61K31/427 ; A61K31/4418 ; A61K31/513 ; A61P31/18
Abstract:
An EL-15 super agonist (IL-15N72D:IL-15RαSU/IgG1Fc; N-803) increases circulating NK cells, effector memory and effector memory RA cells in post-allogeneic hematopoietic stem cell transplant patients (HCT). Methods of treatment include administration of N-803 to subjects in need of such treatment.
Public/Granted literature
- US20210379156A1 TREATMENT OF IMMUNOSUPPRESSED SUBJECTS Public/Granted day:2021-12-09
Information query
IPC分类:
